Supplementation of vitamin E in cats with chronic kidney disease
Malondialdehyde concentration was lower in cats with advanced stages of kidney disease
The aim of this double-blind, placebo-controlled study was to investigate the effect of vitamin E supplementation as an addition to a commercial renal diet on survival time of cats with different stages of chronic kidney disease (CKD). In addition, authors focused whether vitamin E supplementation affects selected oxidative stress and clinical parameters.
Cats with CKD were included and classified according to the IRIS Guidelines. Cats with CKD were treated according to IRIS Guidelines. Cats with CKD were randomly assigned to receive vitamin E (100 IU/cat/day) or placebo (mineral oil) for 24 weeks in addition to standard therapy. Plasma malondialdehyde (MDA) and ...
To read the full article you must log in with your EGO codes.